ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 163 filers reported holding ZAI LAB LTD in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,115 | -4.7% | 87 | +8.8% | 0.00% | – |
| Q2 2023 | $2,219 | -16.6% | 80 | 0.0% | 0.00% | – |
| Q1 2023 | $2,661 | +33.3% | 80 | +23.1% | 0.00% | – |
| Q4 2022 | $1,996 | -50.1% | 65 | -45.4% | 0.00% | -100.0% |
| Q3 2022 | $4,000 | – | 119 | +981.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 11 | -93.1% | 0.00% | -100.0% |
| Q1 2022 | $7,000 | -90.7% | 159 | -86.7% | 0.00% | -88.9% |
| Q4 2021 | $75,000 | -10.7% | 1,198 | +50.9% | 0.01% | -25.0% |
| Q3 2021 | $84,000 | -41.7% | 794 | -2.3% | 0.01% | -42.9% |
| Q2 2021 | $144,000 | +82.3% | 813 | +37.6% | 0.02% | +61.5% |
| Q1 2021 | $79,000 | +16.2% | 591 | +17.3% | 0.01% | 0.0% |
| Q4 2020 | $68,000 | +74.4% | 504 | +8.9% | 0.01% | +62.5% |
| Q3 2020 | $39,000 | +254.5% | 463 | +250.8% | 0.01% | +300.0% |
| Q2 2020 | $11,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |